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Herpes simplex virus (HSV)-associated erythema multiforme (HAEM) is a recurrent disease characterized by the
presence and expression of HSV DNA fragments in lesional skin. Our studies examined the mechanism of viral DNA
transport to the skin of HAEM patients. CD34þ cells were isolated from the blood of normal subjects and HSV and
HAEM patients during acute lesions and at quiescence. They were cultured with cytokines that favor their
differentiation into Langerhans cells (LC) precursors (CD1aþ /CD14) and examined for HSV replication, HSV-
induced cellular alterations, viral DNA fragmentation, and clearance. CD34þ cells from all study groups were non-
permissive for HSV replication but infection favored their differentiation into CD1aþ /CD14 LC precursors and
upregulated E-cadherin expression, thereby assisting LC targeting to the skin. Only HAEM patients had CD34þ
cells that retained viral DNA fragments, notably polymerase DNA, for at least 7 d of in vitro culture. The percentages
of circulating CD34þ (and CD34þ /CLAþ ) cells were significantly higher in HAEM patients at the time of acute
lesions. A similar increase was not seen for HSV patients. The data are the ﬁrst report implicating CD34þ cells in
HAEM pathogenesis, likely by transporting HSV DNA fragments to lesional skin.
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Erythema multiforme (EM) is a polymorphic, often recurring
disease caused by exposure to medication or various in-
fections, notably with herpes simplex virus (HSV). HSV-as-
sociated EM (HAEM) lesions are virus-free (Miura et al,
1992; Aurelian et al, 1998, 2003), but they contain HSV DNA
fragments, most often comprising sequences that encode
the viral DNA polymerase (Pol) (Darragh et al, 1991; As-
lanzadeh et al, 1992; Miura et al, 1992; Imafuku et al, 1997;
Kokuba et al, 1998, 1999a, b; Aurelian et al, 2003; Ng et al,
2003; Sun et al, 2003). Lesion development is initiated by
expression of HSV DNA sequences in the skin (Imafuku
et al, 1997; Kokuba et al, 1998, 1999a, b) and the recruit-
ment of a restricted population of virus-specific T-helper
type 1 (Th1) cells that produce interferon-g (IFN-g) in re-
sponse to the viral antigen in the skin (Kokuba et al, 1998,
1999b; Aurelian et al, 2003). This is followed by an autoim-
mune pathogenesis component resulting from the recruit-
ment of T cells that respond to auto-antigens that are likely
released by lysed/apoptotic virus-infected cells (Aurelian
et al, 2003). Because HSV DNA is transported to peripheral
skin sites of HAEM lesion development before each recur-
rent HAEM episode (Kokuba et al, 1999a), transport plays
a pivotal role in HAEM pathogenesis. The identity of the
transporting cells and their role in DNA fragmentation, how-
ever, are still unknown.
Dendritic cells (DC) form a complex network of cells that
are distributed throughout the body and whose primary
function is antigen presentation and the stimulation of an-
tigen-specific immune responses (Banchereau and Stein-
man, 1998; Banchereau et al, 2000). They are critically
involved in immune responses to viral antigens and the in-
itiation of autoimmune diseases (Salio et al, 1999). Human
DC are generated from CD14þ peripheral blood mon-
ocytes (Randolph et al, 1998) and bone marrow-derived
CD34þ hematopoetic progenitor cells that exist as a trace
population in normal adult blood (Reid et al, 1992). In vitro,
CD34þ cells differentiate into DC by culture with tumor
necrosis factor a (TNF-a) and granulocyte-macrophage col-
ony-stimulating factor (GM-CSF). Differentiation generates
two types of intermediate precursors (immature DC) that
can be identified by the mutually exclusive expression of
CD1a or CD14 antigens. The CD14þ cells mature into in-
terstitial DC-like cells; the CD1aþ cells mature into DC
bearing phenotypic and functional properties of Langerhans
cells (LC) (Sallusto and Lanzavecchia, 1994; Bernhard et al,
1995; Caux et al, 1996, 1997; Strunk et al, 1996; Strobl et al,
1998; Arrighi et al, 2001; Strobl, 2003). Differential expres-
sion of the skin homing cutaneous leukocytes antigen (CLA)
identifies the CD34þ cell subset (CD34þ /CLAþ ) that
gives rise to LC (Herbst et al, 1996; Strunk et al, 1997;
Arrighi et al, 2001; Strobl, 2003).
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The epidermis is continually repopulated by bone mar-
row-derived LC progenitors (Jakob and Udey, 1998; Banc-
hereau et al, 2000). E-cadherin, which is expressed on LC,
but not other DC, is responsible for LC interaction with ker-
atinocytes (KC) (reviewed in Udey, 1997). CD34þ cells and/
or CD34þ -derived LC precursors in the blood stream could
be infected with HSV during their traffic through HSV les-
ional skin, and transport the viral DNA to distal skin sites.
Previous studies have shown that several human viruses
can infect monocyte-derived DC (Grosjean et al, 1997; Cella
et al, 1999; Engelmayer et al, 1999; Ho et al, 2001; Kakimoto
et al, 2002; Kawamura et al, 2003). HSV infection of mon-
ocyte-derived DC inhibits their antigen-presenting function,
causing immune evasion, long-term immunosuppression,
and/or virus spread (Kruse et al, 2000; Mikloska et al, 2001;
Pollara et al, 2003). But the ability of HSV to infect CD34þ
cells, the effect of infection on their differentiation, partic-
ularly into LC precursors, and the potential role of the in-
fected cells in HAEM pathogenesis are still unknown. The
studies described in this report were designed to address
these questions. They indicate that CD34þ cells in the
blood increase in number during acute HAEM episodes and
are involved in disease pathogenesis, likely by transporting
HSV DNA fragments to the skin of HAEM patients.
Results
CD34þ cells do not sustain HSV replication The hy-
pothesis that CD34þ cells transport HSV DNA to the skin
carries the implicit interpretation that they can be infected
with HSV. To test this interpretation, CD34þ cells obtained
with the magnetic curve sorting (MACS) kit from normal
healthy individuals and from lesion-free HAEM and HSV
patients were infected with 106 plaque-forming units (PFU)
of HSV-1 or HSV-2 (MOI  10) and cultured in complete
medium, as described in Materials and Methods. They were
studied for virus growth (by plaque assay) at 4, 12, and 24 h,
and at 7 d post-infection (p.i.) These time points were se-
lected in order to encompass the virus replicative cycle in
permissive cells (24 h) and the endpoint of CD34þ cell
differentiation into immature DC (7 d). In all three study
groups (normal, HSV, and HAEM), virus titers decreased
precipitously (within 4 h) after infection. Residual input virus
(10–1000 PFU per mL) was still seen at 4–24 h p.i., but it
was completely cleared by day 7 p.i. Cord blood CD34þ
cells, which differ from the CD34þ cells in peripheral blood
in terms of differentiation-related properties and their re-
sponse to cytokine stimulation (van den Oudenrijn et al,
2000; Schipper et al, 2003), were similarly non-permissive
for HSV replication. Virus titers decreased by 4 h and all
virus was cleared by 7 d p.i. The data indicate that HSV
infects CD34þ cells, which is consistent with recent find-
ings that they express the virus receptor nectin 1 (Belaaloui
et al, 2003). CD34þ cells, however, do not sustain HSV
replication and are not latently infected with whole virus that
is capable of reactivation. This is independent of the origin
(disease status) of the CD34þ cells.
HSV infection favors CD34þ cells differentiation into
LC precursors CD34þ cells in peripheral blood are com-
mitted to differentiation along two independent pathways
that are characterized by the mutually exclusive expression
of the CD1a or CD14 antigens. CD34þ /CLAþ cells are
committed to become CD1aþ LC precursors that eventu-
ally reside in the skin (Caux et al, 1996, 1997; Herbst et al,
1996; Strunk et al, 1996, 1997; Arrighi et al, 2001; Strobl,
2003). Because cellular gene expression can be altered by
non-productive HSV infection (Taddeo et al, 2002), we
wanted to know whether the differentiation of CD34þ cells
is affected by HSV infection, and whether this differs in
HAEM as compared with HSV patients. Two series of ex-
periments were carried out. First, CD34þ cells from two
normal subjects and from quiescent HSV and HAEM pa-
tients were infected with HSV-1 or HSV-2 (10 PFU per cell)
or mock-infected with phosphate-buffered saline (PBS),
cultured for 7 d in complete medium, and examined for
CD1a and CD14 antigen expression by two-color flow
cytometry. As shown in Fig 1A for HSV-infected CD34þ
cells from one normal subject, the percentages of CD1aþ /
CD14 cells (LC precursors) were, respectively, 5%–5.2%
and 8.1%–10.3% in mock- and HSV-infected cultures, in-
dependent of disease status (normal, HSV, or HAEM). By
contrast, the CD14þ /CD1a cells (progenitors of intersti-
tial-type DC) were minimal in all cultures (0.1%–0.3%), sug-
gesting that HSV infection favors differentiation along the
LC pathway. In addition, the % double-positive cells that
could be gated out by PI staining (dead cells) was also in-
creased in HSV relative to mock-infected CD34þ cell cul-
tures (19%–43% and 2%–5% dead cells, respectively).
In a second series of experiments to examine the effect
of HSV infection on CD34þ cell differentiation, we asked
whether infection alters expression of the homophilic cyto-
adhesion molecule E-cadherin that is involved in the adhe-
sion of LC to KC (reviewed in Udey, 1997). Peripheral blood
mononuclear cells (PBMC) were obtained from two normal
subjects and two quiescent patients, one with HSV and one
with HAEM. They were fractionated with the MACS kit and
the CD34þ cells were mock infected or infected with HSV
(10 PFU per cell) and cultured in complete medium. At 10
and 24 h p.i., cells were examined for E-cadherin expres-
sion by immunoblotting, a sensitive and specific method to
verify gene expression. A431 cells that express E-cadherin
served as positive control (Fig 1B, lane 4). The % express-
ing cells were determined by immunofluorescence flow
cytometry using duplicates of the mock and 10 h HSV-in-
fected cultures. E-cadherin was barely detectable in
immunoblots from mock-infected CD34þ cells (Fig 1B,
lane 1), but its levels were significantly higher at 10 h
(Fig 1B, lane 2) and 24 h (Fig 1B, lane 3) p.i. (Densitometric
integration units¼7.3, 102, and 70 for mock, 10 and 24 h
p.i., respectively). Increased expression does not reflect
improper gel loading or other technical difficulties, because
the levels of actin were virtually identical in all lanes (Fig 1B).
The % E-cadherinþ cells were also 3–3.8-fold higher in
HSV (Fig 1D) than mock (Fig 1C)-infected cultures, sup-
porting the conclusion that HSV favors CD34þ cell differ-
entiation into LC precursors that can reside in the skin. This
was also independent of disease status.
CD34þ cells from HAEM, but not HSV, patients retain
Pol DNA Having observed that HSV infection of CD34þ
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cells is non-permissive, we wanted to verify the state of the
viral DNA in the infected cells. Duplicates of the cultures
studied for infectious virus were examined for the presence
of viral DNA by PCR with Pol primers at 1, 5, and 7 d p.i. The
results are shown in Fig 2A for infected CD34þ and CD34
Figure 1
Herpes simplex virus (HSV) infection favors CD34þ differentiation
along the Langerhans cells pathway. (A) CD34þ cells from a normal
subject infected with HSV-1 and cultured in complete medium for 7 d
were analyzed for CD1a (fluorescein isothiocyante (FITC) fluorescence
intensity) and CD14 (phycoerythrin (PE) fluorescence intensity) antigen
expression by two-color flow cytometry. Mock-infected cells studied in
parallel had approximately 2-fold lower levels of CD1aþ /CD14 cells
and double-positive cells could be gated by PI staining dead cells (data
not shown). Similar results were obtained for HSV and HSV-associated
erythema multiforme (HAEM) patients. (B) CD34þ cells obtained with
the MACS kit from a quiescent HSV patient were mock infected (lane 1)
or infected with HSV and cultured in complete medium for 10 h (lane 2)
or 24 h (lane 3). A431 cells (lane 4) served as positive control. Cell
extracts were examined for E-cadherin expression by immunoblotting
with E-cadherin antibody. The blots were stripped and re-probed with
antibody to actin. Similar results were obtained in CD34þ cells from
HAEM patients or normal adult subjects. (C, D) Duplicates of the mock
(C) or 10 h HSV (D)-infected samples in (B) were stained with E-cad-
herin antibody and examined by flow cytometry.
Figure2
CD34þ cells from herpes simplex virus (HSV)-associated ery-
thema multiforme (HAEM) patients are impaired in viral DNA clear-
ance. (A) CD34þ and CD34 cells obtained with the MACS kit from
quiescent HAEM and HSV patients were infected with 106 plaque-
forming units of HSV-2 and examined for viral DNA by PCR with po-
lymerase (Pol) and ICP27 primers. The 92 bp Pol amplificant is shown in
lanes 2–9 for CD34þ and CD34 cells from HSV (lanes 2–5) and
HAEM (lanes 6–9) patients at 1 and 7 d post-infection (p.i.) The 169 bp
ICP27 amplificant is shown in lanes 10–11 for an HAEM patient at 4 and
24 h p.i. Similar results were obtained for cells infected with HSV-1.
Lane 1 represents molecular weight markers. (B) Percentage of HAEM
and HSV patients with CD34þ cells positive for Pol DNA at various
times p.i. with HSV-1. Similar results were obtained for HSV-2. (C)
CD34 cells from a quiescent HAEM patient (obtained with the MACS
kit) were enriched in CD14þ cells by adhesion to plastic as described
in Materials and Methods, and the CD14þ cells were infected with
HSV-1. They were assayed for viral DNA by PCR with primers for Pol
(lanes 2–4) or ICP27 (lanes 5–7) at 1–5 and 7 d of culture in complete
medium. Similar results were obtained for HSV patients and in cells
infected with HSV-2. Lane 1 represents molecular weight markers.
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cells from two patients, and summarized in Fig 2B for
CD34þ cells from all patients. CD34þ cells from cord
blood, normal adult subjects, and HSV patients showed a
time-dependent clearance of the viral DNA, with all subjects
becoming DNA-free on day 7 p.i. (Fig 2A, lanes 2 and 3;
Fig 2B). By contrast, CD34þ cells from the HAEM patients
were positive for Pol DNA throughout the 7 d of in vitro
culture (Fig 2A, lanes 6 and 7; Fig 2B), indicating that they
are impaired in viral DNA clearance.
To examine whether the viral genome is fragmented in
infected CD34þ cells, duplicates of the HSV-infected
CD34þ cultures from HAEM patients were assayed by
PCR with infected cell protein 27 primers at 4 and 24 h p.i.
These primers were selected because: (i) ICP27 is located
close to the opposite end of the viral genome relative to Pol,
(ii) ICP27 and Pol primers are equally sensitive (Imafuku
et al, 1997), and (iii) Pol, but not ICP27, DNA is present in
lesional skin from most HAEM patients (Imafuku et al, 1997;
Aurelian et al, 2003), a finding confirmed in our patients
(data not shown). As shown in Fig 2A, lanes 10 and 11 for
one HAEM patient, ICP27 DNA was seen in CD34þ cul-
tures from 30% of the patients at 4 h p.i. One-third of these
patients (10%) were still positive for ICP27 DNA at 24 h p.i.
(data not shown). Because all the HAEM patients were
positive for Pol DNA as late as 7 d p.i., the data suggest that
HSV DNA is rapidly fragmented in these cultures, likely as
an outcome of non-permissive infection. The mechanism
responsible for the lower stability of ICP27 as compared
with Pol DNA is still unknown.
As further control for these data, CD34 cell fractions
obtained from the same patients as a result of the MACS
fractionation were studied in parallel. Virus titration at 4, 12,
and 24 h and at 7 d p.i. indicated that CD34 cells are also
non-permissive for virus replication. CD34 cells from both
HAEM (Fig 2A, lanes 8 and 9) and HSV (Fig 2A, lanes 4 and
5) patients, however, were positive for Pol DNA at 1–7 d p.i.,
indicating that the differential DNA clearance seen in
CD34þ cells is specific for HAEM patients. Studies of
CD34 fractions enriched in CD14þ cells (monocytes) by
adhesion to plastic (2 h at 371C) suggested that the viral
DNA is in monocytes. Thus, the adherent cells (80%–85%
CD14þ ) were infected with HSV-1 or HSV-2 (10 PFU per
cell), cultured in complete medium, and examined for viral
DNA by PCR with Pol and ICP27 primers at 1–7 d p.i. Pol
DNA was seen in the CD14þ cells from both HAEM and
HSV patients at all times in culture whereas ICP27 DNA
was seen in 20% of the patients at 1 d p.i., but not later
(Fig 2C). HSV DNA was not seen in CD19þ cells (B cells)
fractionated from the CD34 population with the ap-
propriate MACS separation kit and used as control (data
not shown). Collectively, the data indicate that viral
DNA clearance is only impaired in CD34þ cells from HAEM
patients. Since the CD34þ fractions contain 7%–15%
CD34 cells that retain Pol DNA, the failure to detect
viral DNA in the CD34þ cultures from normal subjects
and other HSV patients suggests that it is degraded by
viral or virus-induced/activated cellular nuclease(s) that are
not expressed/functional in CD34þ cells from HAEM pa-
tients. The data support the conclusion that CD34þ and
CD34 cells do not retain the whole virus that is capable of
reactivation.
CD34þ cells from HAEM patients evidence increased
HSV-induced apoptosis Having seen that HSV infection
can also cause cell death, we wanted to know whether it is
because of apoptosis (as previously shown for monocyte-
derived DC; Salio et al, 1999; Kruse et al, 2000; Mikloska
et al, 2001; Pollara et al, 2003), and whether this differs for
HAEM as compared with HSV patients. CD34þ cells from
quiescent HSV and HAEM patients were infected with 10
PFU per cell of HSV-1 or HSV-2 and cultured in complete
medium. At various times p.i. (0, 4, 12, and 24 h, 5 and 7 d),
the cells were centrifuged onto glass slides and assayed
for apoptosis by TdT-mediated dUTP nick end labeling
(TUNEL). Cells in five different fields were counted (at least
350 cells) and the % TUNELþ cells were calculated. Re-
sults are expressed as % TUNELþ cells  SEM. The %
TUNELþ (apoptotic) cells in mock-infected CD34þ cells
were very low for both HAEM and HSV patients (1% 
0.2%–3.9%  0.1%). HSV infection caused a significant
Figure3
CD34þ cells from herpes simplex virus (HSV)-associated ery-
thema multiforme (HAEM) patients evidence increased HSV-in-
duced apoptosis. CD34þ (A) and CD34 (B) cells from quiescent
HAEM and HSV patients were mock-infected or infected with 10
plaque-forming units per cell of HSV-1 and cultured in complete me-
dium. At various times p.i., the cells were centrifuged onto glass slides
and assayed by TdT-mediated dUTP nick end labeling (TUNEL) using
the In Situ Cell Death Detection Kit. Cells in five different fields were
counted (at least 350 cells) and the % TUNELþ (apoptotic) cells
were calculated. Results are expressed as % TUNELþ cells  SEM
(po0.001 by ANOVA vs HSV patients).
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(po0.001) increase in the % TUNELþ cells in the HAEM
patients (45% on days 5 p.i.), but the % TUNELþ cells in
infected CD34þ cells from HSV patients were significantly
(po0.001) lower (20% on day 5 p.i.) (Fig 3A). The %
TUNELþ cells in CD34 cell cultures (used as control)
were similar in HAEM and HSV patients, and similar to those
seen for CD34þ cells from HSV patients (15% on day 5 p.i.)
(Fig 3B). The data indicate that: (i) HSV triggers apoptosis in
CD34þ and CD34 cells, and (ii) CD34þ cells are sig-
nificantly more susceptible to HSV-induced apoptosis in
HAEM than HSV patients.
The % CD34þ cells in peripheral blood is increased dur-
ing acute HAEM episodes Having seen that CD34þ cells
from HAEM and HSV patients respond differently to HSV
infection, we wanted to know whether patients in the two
study groups differ in terms of the numbers of CD34þ cells
at various stages of the disease. PBMC were obtained from
HAEM and HSV patients at the time of acute disease (days
1–3 after HSV and 2–8 after HAEM lesion onset) and during
quiescence (free of clinical symptoms). They were exam-
ined for CD34þ and CD34þ /CLAþ cells by double imm-
unofluorescence with phycoerythrin (PE)-labeled CD34 and
fluorescein isothiocyante (FITC)-labeled CLA antibodies by
flow cytometry. CD34þ /CLAþ cells were examined be-
cause they give rise to LC (Herbst et al, 1996; Strunk et al,
1997; Arrighi et al, 2001; Strobl, 2003). PBMC from three
normal subjects served as control. The results of these
studies are shown in Fig 4 for two patients and one normal
subject and summarized in Table I, for all patients. The per-
Figure 4
The percentages of CD34þ and CD34þ /CLAþ
(cutaneous leukocytes antigen) cells are in-
creased during acute herpes simplex virus
(HSV)-associated erythema multiforme (HAEM)
episodes. Peripheral blood mononuclear cells ob-
tained from a normal HSV-negative subject and from
an HAEM and an HSV patient during quiescence
and at the time of an acute episode were examined
for CD34 and CLA expression by two-color flow
cytometry. CLA expression was determined by
measuring fluorescein isothiocyante (FITC) flu-
orescence intensity, and CD34 expression was
determined by measuring phycoerythrin (PE) fluo-
rescence intensity. Similar results were obtained for
all patients (Table I).
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centages of CD34þ cells in the quiescent HSV
(3.9%  1.8%) and HAEM (4.6%  1.8%) patients were
similar, but somewhat higher than those (2.0%  0.1%) in
normal adult blood. Similar percentages of CD34þ cells
(5.6%  1.1%) were seen in patients with acute HSV epi-
sodes, but the percentages of CD34þ cells in patients with
acute HAEM lesions were significantly higher (27% 
2.0%). The CD34þ /CLAþ cells were 50%–65% of the to-
tal CD34þ cell populations in all study groups, being
2.0%  0.7% and 2.7%  0.9% in quiescent HAEM and
HSV patients and 17.5%  2.5% and 3.8%  0.8% in acute
HAEM and HSV patients, respectively. The CD34þ /CLAþ
cells in the normal subjects were 0.9%  0.2%. The
increased percentage of CD34þ and CD34þ /CLAþ cells
during acute HAEM episodes is not because of improper
patient selection, because the same patients were studied
during quiescence and acute disease episodes. In this
context, it may also be important to point out that the per-
centage of CLAþ /CD34 cells (8.4%–11%) were similar in
HAEM patients with quiescent or acute episodes. The data
suggest that CD34þ cells are involved in HAEM patho-
genesis, presumably by transporting viral DNA to distant
skin sites.
HSV, but not HAEM lesional skin, contains Pol DNAþ
CD34 cells To further test the hypothesis that CD34þ
cells transport viral DNA to HAEM skin, we asked whether
CD34þ and/or CD34 cells from HSV and HAEM lesional
skin are positive for viral DNA. Infiltrating PBMC were iso-
lated by Ficoll–Hypaque gradient centrifugation from punch
biopsies (4 mm) obtained from HSV and HAEM lesions from
one patient (day 2 post-HSV and day 8 post-HAEM lesion
onset) and further fractionated with the MACS kit. The
numbers of CD34þ cells (8  102 and 3  103 for HSV and
HAEM lesions, respectively) were close to the sensitivity
limit of the PCR assay (Imafuku et al, 1997). By contrast, the
numbers of CD34 cells (2  104 and 5  104 for HSV and
HAEM lesions, respectively) were sufficient for PCR analysis
and they were examined in parallel with DNA extracted from
the skin tissues. Pol was amplified from the HAEM and HSV
skin tissues (Fig 5, lanes 1 and 3) and from the CD34
fractions isolated from the HSV skin lesion (Fig 5, lane 2).
CD34 cells from the HAEM skin lesion were negative for
Pol DNA (Fig 5, lane 4), suggesting that the DNA in the
HAEM skin is not in CD34 cells.
Discussion
HAEM pathogenesis is associated with the presence and
expression of HSV DNA fragments that are transported to
HAEM lesional skin before each recurrent episode (Imafuku
et al, 1997; Kokuba et al, 1998, 1999a, b; Aurelian et al,
2003). The salient feature of the data presented in this report
is the finding that transport appears to be mediated by in-
creased numbers of circulating CD34þ cells. The following
comments seem pertinent with respect to these findings.
These studies were stimulated by previous observations
that HSV DNA is transported to the HAEM skin by the vas-
cular route (Aurelian et al, 1998; Kokuba et al, 1999a), and its
deposition is likely to involve increased expression of the ad-
hesion protein ICAM-1 in microvascular endothelial cells
(Bruynzeel et al, 1993; Larcher et al, 2001). They focused on
CD34þ cells because these cells traffic from the bone mar-
row through the blood stream, undergoing a maturation
Table I. CD34þ and CD34þCLAþ cell numbers are increased
during acute HAEM
Diagnosis Total CD34þ (%) CD34þCLAþ (%)
Normal 2.0  0.1 (po0.001) 0.9  0.2 (po0.001)
Acute HAEM 27.0  2.0 17.5  2.5
Quiescent HAEM 4.6  1.8 (po0.001) 2.0  0.7 (po0.001)
Acute HSV 5.6  1.1 (po0.001) 3.8  0.8 (po0.001)
Quiescent HSV 3.9  1.8 (po0.001) 2.7  1.9 (po0.001)
PBMC were collected from three normal subjects and from four HAEM
and eight HSV patients. They were obtained at the time of acute disease
(days 1–3 after onset of HSV and 2–8 after onset of HAEM lesions) and
during quiescence (3–6 wk after lesion resolution; free of clinical symp-
toms). Cells were analyzed by double immunofluorescent staining with
PE-labeled CD34 and FITC-labeled CLA antibodies and flow cytometry.
Results are expressed as the mean cell population number  SEM.
Statistical analysis compared each cell population with the acute
HAEM patient group by ANOVA.
Differences between the acute and quiescent HSV and the quiescent
HAEM groups were not statistically significant (p40.05). These three
groups were somewhat, but not significantly, higher than normal subjects.
CLA, cutaneous leukocytes antigen; HAEM, herpes simplex virus
(HSV)-associated erythema multiforme; PBMC, peripheral blood mono-
nuclear cells; PE, phycoerythrin; FITC, fluorescein isothiocyante. Figure5
CD34 cells from herpes simplex virus (HSV), but not HSV-asso-
ciated erythema multiforme (HAEM) lesions, are positive for po-
lymerase (Pol) DNA. Biopsy samples were minced with forceps and
scissors in complete medium, and infiltrating lymphocytes were sep-
arated by Ficoll–Hypaque density gradient centrifugation. CD34þ /
fractions were obtained with the MACS kit. DNA extracted from the
lesional skin and from CD34 cell fractions was assayed by PCR with
Pol primers. The 92 bp Pol amplificant was seen in skin from HSV (lane
1) and HAEM (lane 3) lesions and in CD34 cells isolated from the HSV
lesion (lane 2). CD34 cells isolated from the HAEM lesion were free of
Pol DNA (lane 4). The numbers of isolated CD34þ cells were too small
for study.
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process that begins with immature DC. In peripheral blood,
CD34þ cells represent early committed progenitors. At 5–7 d
of in vitro culture with TNF-a and GM-CSF, they give rise to
two subsets of DC precursors, one of which (CD1aþ /
CD14) develops into LC that continually repopulate the ep-
idermis (reviewed in Udey, 1997). We found that under the
experimental conditions used in our studies, CD34þ cells
from normal adult subjects or cord blood, as well as CD34þ
cells from the blood of adult HSV and HAEM patients were
non-permissive for the growth of both HSV serotypes. Virus
titers decreased precipitously within the first 4 h p.i. and re-
sidual virus was completely lost by 7 d p.i., indicating that
CD34þ cells do not sustain virus replication and they are not
carriers of latent HSV. But infection favored cell differentiation
along the LC pathway (2-fold increase in the % CD1aþ /
CD14 cells relative to mock-infected cultures) and it in-
creased expression of E-cadherin, which favors LC residence
in the epidermis (reviewed in Udey, 1997). This likely reflects
virus-induced upregulation of cellular genes that is replication
independent (Taddeo et al, 2002). The percentages of
CD14þ /CD1a cells (progenitors of interstitial-type DC)
were minimal, and similar for both HSV- and mock-infected
cultures. E-cadherin upregulation early p.i. may represent a
mechanism of virus spread that is limited by the non-permis-
sive nature of the CD34þ cell infection and is independent of
the origin of the CD34þ cells (normal subjects or patients
with HSV or HAEM).
CD34þ cells from normal subjects, cord blood, and HSV
patients evidenced a time-dependent loss of viral DNA that
was no longer seen at 7 d p.i. By contrast, CD34þ cells
from the HAEM patients were impaired in viral DNA clear-
ance, thereby providing a unique opportunity for its delivery
to the skin. We conclude that DNA is fragmented in CD34þ
cells, because ICP27 DNA was lost by CD34þ cells from
most HAEM and HSV patients (70%) during the first 4 h p.i.,
indicative of the different stability of the various fragments of
viral DNA. Pol DNA retention by CD34þ cells from HAEM
patients indicates that these cells process the viral DNA
differently than CD34þ cells from other subjects, including
HSV patients. Differential processing of the viral DNA was
not seen in CD34 cells from the same patients, under-
scoring the distinct interaction of HSV with CD34þ cells
from HAEM patients. In this context, it is important to point
out that the CD34þ cell fractions used in these studies
were contaminated by approximately 7%–15% CD34
cells that retain viral DNA at 7 d p.i. Therefore, detection
of Pol DNA in CD34þ cells from HAEM patients but not
other study groups suggests that viral or virus-induced/
activated cellular nuclease(s) are not upregulated/functional
in CD34þ cells from HAEM patients.
Despite the high MOI (10 PFU per cell) used in these
studies, HSV infection caused cell death in a proportion, but
not all, CD34þ cells. Death was because of apoptosis, as
determined by a higher % TUNELþ cells in HSV than
mock-infected cultures. The highest % TUNELþ cells was
seen in HAEM patients (45%), however, supporting the
conclusion that their CD34þ cells respond differently to
HSV infection. Presumably, infection affected different cel-
lular genes, with apoptotic cascades stimulated in 45% of
the cells whereas 10% of the cells were stimulated to dif-
ferentiate into CD1aþ LC precursors. Mechanisms respon-
sible for the differential response of various infected cells
are still unknown. But the higher percentage of apoptotic
CD34þ cells in HAEM patients could contribute to the au-
toimmune component of HAEM (Aurelian et al, 2003) be-
cause apoptotic DC are likely to be ingested by normal
uninfected DC, LC, and/or macrophages involved in antigen
presentation (von Bubnoff et al, 2001).
The % CD34þ and CD34þ /CLAþ cells detected by
FACS analysis in PBMC from normal healthy subjects were
somewhat higher than those previously reported after ex-
tensive cell fractionation procedures (Reid et al, 1992) and
may reflect the use of different technology for their isolation/
identification. We do not believe that our data are because
of technical errors, because: (i) the FACS assay is estab-
lished and internally controlled, (ii) our findings for CD4þ /
CD25þ cells studied in parallel for some of these patients
(6.2%–10.4% of CD4þ T cells) were similar to those (5%–
15% of CD4þ T cells) independently reported by others
(Tang et al, 2003), and (iii) approximately one half of the
CD34þ cells were CLAþ , as also reported by others for
normal adults (Strunk et al, 1996). The somewhat increased
percentages of CD34þ and CD34þ /CLAþ cells in HSV
patients may represent a host attempt to overcome immune
evasion resulting from the inhibitory effects of virus infection
of monocyte-derived DC (Kruse et al, 2000; Mikloska et al,
2001; Pollara et al, 2003). The present data do not address
the mechanism responsible for this increase. It is particu-
larly relevant, however, that the percentages of circulating
CD34þ (and CD34þ /CLAþ ) cells were significantly in-
creased during acute episodes of HAEM, when viral DNA is
transported to the skin (Kokuba et al, 1999a). The increase
was disease related, because: (i) the same patients were
studied during acute episodes and at quiescence, and (ii) a
similar increase was not seen during acute HSV episodes.
This conclusion is also supported by the findings that: (i)
CD34þ cells from HAEM patients preferentially retain Pol
DNA throughout their differentiation into LC precursors, and
(ii) HSV infection favors their differentiation into LC precur-
sors, and increases the expression of E-cadherin that
facilitates LC population of the epidermis. Presumably,
CD34þ cells and/or LC precursors derived from them pick
up the virus when they migrate through HSV lesional skin,
whether through direct infection or by endocytic capture of
dying infected cells. Although our data indicate that the viral
DNA is fragmented in the infected CD34þ cells, we do not
exclude the possibility that the migrating CD34þ cells may
also pick up viral DNA fragments. Either way, however, the
outcome is Pol DNA transport to distal skin sites by the LC
precursors. Significantly, because LC have a relatively
long life-span in the periphery under steady-state condi-
tions (Merad et al, 2002), our data carry the implicit con-
clusion that HSV infection accelerates LC replacement in
the skin.
Consistent with the conclusion that CD34þ cells trans-
port Pol DNA to the skin of patients with HAEM, Pol DNA
was found in CD34 cells from HSV, but not HAEM lesional
skin, although both skin tissues were DNAþ . Additional
CD34þ cells, immature DC, and auto-antigen-specific Th1
cells are further mobilized to the skin by chemokines, such
as MCP-1 and RANTES (Xu et al, 1996; Dieu et al, 1998),
that are expressed in lesional skin (Spandau et al, 2002).
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Indeed, media conditioned by CD34þ cells contain chemo-
attractants for other CD34þ cells (Majka et al, 2001) and
antigen- or chemokine-stimulated CD34þ cells produce/
secrete regulatory mediators that may contribute to inflam-
matory and immune processes (Umland et al, 2004). The
unique response of CD34þ cells from HAEM patients is
consistent with the genetic theory of HAEM pathogenesis
(Khalil et al, 1991). Indeed, five of 11 (45.5%) independently
studied HAEM patients had HLA DQB1 0301 allele and of
these five patients, four also had a DQA10505 allele. The
latter subset included our HAEM patients with the more
severe and longer-lasting lesions (unpublished).
Our data do not exclude the possibility that monocytes
can also transport viral DNA to the skin (Aurelian et al,
1998), at least under specific conditions. If various PBMC
subpopulations pick up HSV from skin lesions, HAEM de-
velopment after some but not other HSV episodes experi-
enced by the same patient (Kokuba et al, 1999a) may be
determined by the specific cell subset that is involved in
DNA transport (e.g. macrophages, monocyte-derived DC,
or CD34þ -derived LC precursors). However, random virus
uptake is unlikely to be responsible for HAEM development
in some, but not other HSV patients, because IFN-g and
chemokines in HSV lesions (Kokuba et al, 1999b) contribute
to the mobilization, homing, and recruitment of most PBMC
subpopulations. This includes CD34þ cells, which express
the CXCR3 receptor during proliferation and differentiation
(Jinquan et al, 2001). Ongoing studies are designed to ex-
amine the presence of HSV DNA in circulating CD34þ cells
from HAEM and HSV patients at different stages of the dis-
ease, and determine the contribution of genetic components
(Khalil et al, 1991) to the distinct response of CD34þ cells
from HAEM patients to virus infection.
Materials and Methods
Study groups Thirteen patients with a history of recurrent HAEM
and 18 patients with a history of recurrent HSV-1 (12 patients)
or HSV-2 (six patients) were studied. Diagnosis was confirmed
by virus isolation (HSV patients) and by PCR of lesional skin
(obtained by punch biopsy) with Pol primers, as previously
described (Miura et al, 1992; Imafuku et al, 1997; Kokuba et al,
1998, 1999a, b). Blood samples (50 mL) were obtained at the time
of acute lesions (days 1–3 after HSV lesion onset; days 2–8 after
HAEM lesion onset) and during lesion-free intervals (at least 3 wk
after lesion healing). Four adult subjects who denied a previous
history of HSV infection and were seronegative for both HSV-1
and HSV-2 determined by gG ELISA (Focus Technologies, Cyprus,
California) served as normal control. The medical ethical commit-
tee of the University of Maryland approved all the described
studies. The study was conducted according to the Declaration
of Helsinki Principles. Participants gave their written informed
consent.
Cells and viruses Vero (African green monkey kidney) cells were
grown in Eagle’s-modified minimal essential medium (EMEM) (In-
vitrogen, Carlsbad, California) with 10% fetal bovine serum (FBS)
and 100 U per mL penicillin–streptomycin (Gibco-BRL, Gait-
hersburg, Maryland). HSV-1 (strain F) and HSV-2 (strain G) were
as previously described (Gyotoku et al, 2002). They were grown
in Vero cells and clarified of cell debris by centrifugation at
20,000  g. The clarified supernatant was subjected to ultracen-
trifugation (2 h, 114,000 g) in a Beckman SW501 rotor and the
pelleted virus (partially purified) was resuspended in fresh MEM
and stored at 801C until use. Virus titers were determined by
plaque assay on Vero cells and expressed as PFU per mL (Au-
relian, 2000). Mock infection with PBS served as control.
Antibodies Mouse monoclonal antibodies (Mab) to human CD34
(581), CD1a (HI149), CD14 (M5E2), and CD19 (HIB19) antigens and
rat anti-human Mab to CLA (HECA-452) antigen were obtained
from BD Biosciences PharMingen (San Diego, California). The an-
tibodies to CD14, CD19, and CD34 were conjugated to R-PE.
Those against CLA and CD1a were conjugated to FITC. R-PE-
conjugated mouse IgG2a k, mouse IgG1 k, and rat IgM K and
FITC-conjugated mouse IgG1 k were also obtained from BD Bio-
sciences Pharmingen and, respectively, used as matched isotype
controls for CD14 (mouse IgG2a), CD34, CD1a, and CD19 (mouse
IgG1), and CLA (rat IgM). Affinity-purified rabbit anti-E-cadherin
IgG (H-108) and goat anti-actin IgG (C-11) were obtained from
Santa Cruz Biotechnology (Santa Cruz, California), normal rabbit
IgG from Calbiochem (San Diego, California), and HRP-conjugated
anti-rabbit IgG was obtained from Cell Signaling Technology (Be-
verly, Massachusetts) and used according to the manufacturer’s
instructions.
PBMC collection and culture of CD34þ , CD34, and CD14þ
cells PBMC were isolated using discontinuous Ficoll/Hypaque
(Pharmacia, Uppsala, Sweden) density gradient centrifugation.
PBMC obtained by Ficoll–Hypaque centrifugation from 50 mL of
blood collected during quiescence were fractionated with the
MACS kit, according to the manufacturer’s instructions. CD34þ
and CD34 fractions were obtained from the PBMC using the
MACS Direct CD Progenitor Cell Isolation Kit and MiniMACS sep-
aration columns (Miltenyi Biotec, Auburn, California), according to
the manufacturer’s instructions. CD34þ cells averaged 2.1 
1.2  105 and 1.4  0.8  105 cells for HAEM and HSV patients,
respectively. For all patients, the purity of the CD34þ population
ranged between 85% and 93% as determined by staining with
CD34-specific antibody and flow cytometry analysis. Two-color
flow cytometry with PE- and FITC-labeled CD34 and CLA anti-
bodies indicated that 54%–60% of the CD34þ cells expressed
CLA (CD34þ /CLAþ ). Cord blood CD34þ cells were purchased
from Cambrex BioScience (Rockland, Maryland).
Primary cultures of CD34þ cells were established in 24-well
plates (Costar, Cambridge, Massachusetts) seeded with 104 cells
per well at 371C in a humidified atmosphere in the presence of 5%
CO2. The medium consisted of RPMI 1640 containing 2.05 mM L-
glutamine (Invitrogen) with 10% heat-inactivated FCS (Gemini Bio-
Products, Woodland, California) and supplemented with optimized
concentrations of GM-CSF (50 ng per mL) (Sigma, St Louis, Mis-
souri), TNF-a (10 ng per mL) (R&D Systems, Minneapolis, Minne-
sota) (Caux et al, 1996, 1997; Strunk et al, 1996, 1997), and IL-4 (20
ng per mL) (Sigma) (complete medium). IL-4 was added to the
medium because it blocks the CD14 maturation pathway when
added to CD34þ cells and enhances the survival of LC-like DC
(Romani et al, 1994; Canque et al, 1998; Rougier et al, 1998). Pri-
mary cultures of CD34 cells were set up in parallel and served as
control. CD14þ enriched populations were obtained from the
CD34 fraction by adhesion to plastic (2 h at 371C) followed by
removal of the contaminating cells by four washes with PBS. More
than 60% of the attached cells expressed the CD14 marker, as
determined by flow cytometry. The CD14þ enriched cell popula-
tions were cultured in RPMI-10% FBS supplemented with GM-
CSF (50 ng per mL) and IL-4 (20 ng per mL) for 5 d (generate
immature DC) and for 2 additional days in the same medium sup-
plemented with TNF-a (50 ng per mL). Cells were infected with
HSV-1 or HSV-2, as described (Aurelian, 2000). Adsorption was for
1 h at 371C. Unbound virus was removed by extensive washing
and the cells were re-incubated in complete medium. Cultures
were collected at various times p.i. and duplicates were examined
for virus titers or viral DNA by PCR.
Immunoﬂuorescence and ﬂow cytometry For membrane stain-
ing, 50 mL of cells (5  106 to 107 per mL) were incubated (30 min)
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with 20 mL of conjugated Mab. Cells were washed and expression
of the cell surface molecules was examined by flow cytometry
using the FACScalibur system equipped with CellQuest software
(both from Becton Dickinson Immunocytometry Systems, San
Jose, California), as previously described (Aurelian et al, 2001).
Fluorescence from FITC-labeled cells was collected using a 530
per 30 nm band pass filter whereas PE fluorescence was meas-
ured with a 580 per 25 nm band pass filter. After gating with
the respective isotype-matched immunoglobulin, percentages of
staining cells and mean fluorescence calculations were determined
from the histogram and dot plot displays using CellQuest software
(Becton Dickinson Immunocytometry Systems).
PCR ampliﬁcation DNA was extracted from HSV or mock-infect-
ed CD34þ , CD34, or CD14þ cells and amplified by PCR with
the HSV-type common primers for HSV DNA Pol (50-CATCACCG
ACCCGGAGAGGGAC-30 and 50-GGGCCAGGCGCTTGTTGGTG
TA-30) or ICP27 (50-AGGACATTGCATCCTTCGTG-30 and 50-GTGC
GTGTCTAGGATTTCGA-30). The sensitivity and specificity of the
primers were previously described (Miura et al, 1992; Imafuku et al,
1997). Thermal cycles included 1 min denaturation (941C) followed
by 30 cycles consisting of 941C for 30 s, 551C for 30 s, and 721C for
1min. PCR was completed with an extension step of 7 min at 721C.
The Pol and ICP27 genes were targeted because they are located
at distant sites on the HSV genome and the primers used for their
detection are equally sensitive (Imafuku et al, 1997). Consequently,
detection of both Pol and ICP27 DNA is indicative of the presence
of the entire viral genome, whereas detection of only one of these
DNA sequences is evidence of fragmentation (Aurelian et al, 2003).
Negative controls present between samples included DNA from
uninfected Vero cells and amplification with b-globin primers (Miura
et al, 1992; Imafuku et al, 1997).
TUNEL assay CD34þ and CD34 cells were infected with 10
PFU per cell of HSV-1 or HSV-2 and cultured with cytokines that
induce DC development, as above. At various times p.i. (0, 4, 12,
24 h, 5, 7 d), the cells were centrifuged onto glass slides and
assayed by TUNEL using the In Situ Cell Death Detection Kit
(Roche Molecular Biochemicals, Indianapolis, Indiana) according
to the manufacturer’s instructions. Cells in five different fields were
counted (at least 350 cells) and the % TUNELþ cells were cal-
culated. Results are expressed as % TUNELþ cells  SEM, as
previously described (Perkins et al, 2003).
Immunoblotting CD34þ cells (3.3  105) and CD14þ cells
(1  107) were mock infected or infected with HSV-2 (10 PFU per
cell) and incubated in complete medium for 10 or 24 h. At this time,
the cells were washed with PBS and resuspended in 70 mL of RIPA
buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40,
1% sodium deoxycholate, 0.1% SDS) supplemented with phos-
phatase and protease inhibitor cocktails (Sigma). For each time
point, proteins in the entire extract of CD34þ cells or 100 mg of the
CD14þ cells extract were resolved by SDS-PAGE and transferred
to nitrocellulose membranes. The blots were blocked for 1 h at
room temperature with blocking buffer (TN-T buffer, 0.01 M Tris-
HCl, pH 7.4, 0.15 M NaCl, 0.05% Tween-20) containing 5% nonfat
milk (w/v) and incubated with antibody to E-cadherin (1:200 dilu-
tion) for 1 h at room temperature. After three washes, blots were
incubated with a 1:2000 dilution of HRP-conjugated anti-rabbit IgG
(in blocking buffer) for 1 h at room temperature followed by four
additional washes. Detection was with ECL reagents (Amersham
Life Science, Arlington Heights, Illinois) followed by exposure to a
high-performance chemiluminescence film (Hyperfilm ECL, Amer-
sham Life Science). Quantitation was by densitometric scanning
using the Bio-Rad GS-700 Imaging Densitometer (Smith et al,
2000; Perkins et al, 2003).
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